TIDES USA is a leading scientific and industry forum that brings together global experts in oligonucleotide, peptide, mRNA, genome editing and drug delivery to share cutting-edge research, development strategies and commercialization insights. The event features multiple concurrent tracks, workshops, poster sessions and networking opportunities designed to accelerate next-generation therapeutics from discovery through manufacturing and market launch.

Date: May 11-14, 2026
Location: Boston, Massachusetts
Event Website: https://informaconnect.com/tides/

JOIN US!

Discover how Catalent is advancing oral drug development and delivery of macromolecules with modified release technology, bioavailability enhancement and scientific innovation. Schedule a meeting with our experts to see how we can support your next breakthrough.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Amruta Mhashilkar, Associate Director, Formulation & Process Development
Date: Wednesday, May 13, 2026 at 1:00pm
Title: Overcoming Barriers to Oral Delivery of Macromolecules Through Innovative Technologies

Oral delivery of peptides and proteins remains constrained by gastrointestinal instability, enzymatic degradation, and limited permeability. Emerging technologies—including advanced lipid-based formulations, delayed-release softgels, and buccal or sublingual systems—offer strategies to protect molecules, enable targeted intestinal release, as well as lymphatic delivery. This presentation will examine how these approaches can improve exposure and unlock clinically meaningful oral delivery of macromolecules with data.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™